# ENDRA Life Sciences Inc.: Form 8-K, filed Jun 23, 2022

- Company: [ENDRA Life Sciences Inc.](/companies/ndra.md) (CIK 1681682)
- Form: 8-K
- Filed: 2022-06-23
- Accepted by EDGAR: Jun 23, 2022, 16:00 ET
- Period: 2022-06-22
- Accession: 0001654954-22-008684
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1681682/000165495422008684/endra_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1681682/000165495422008684/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1681682/000165495422008684/endra_8k.htm

Filed Jun 23, 2022.
Source: SEC EDGAR, the filing index for accession 0001654954-22-008684. Last ingested by Listed: Nov 10, 2026, 17:03 ET. No prices; not investment advice.
